Cellbxhealth PLC
ANPCF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | -56.5% | 0% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 58.5% | 58.5% | 63.9% | 63.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,160.3% | -1,160.3% | -348.1% | -348.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,164.3% | -1,164.3% | -356.2% | -356.2% |
| EPS Diluted | -0.014 | -0.014 | -0.01 | -0.01 |
| % Growth | 0% | -42.6% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |